The core activity of Pentapharm is the development and manufacture of innovative solutions for the diagnosis and treatment of coagulation disorders. This includes the production of diagnostic kits and reagents, peptides, enzymes and active pharmaceutical ingredients (APIs) for the pharmaceutical industry. The company focuses on the areas of haemostasis, thrombosis and bleeding and offers products and solutions for the prevention and treatment of coagulation disorders.
AI-generated
Comparisons
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.